Caixin App
Newsletter
Go
Sections
Sections
Finance
Business
Tech
Economy
China
World
Opinion
Weekend Long Read
Research & Analysis
Lifestyle
Books & Arts
Blog
Video
Topics
Asia New Vision Forum
War in Ukraine
Evergrande Crisis
ESG & Carbon Goals
China-U.S. Rivalry
Coronavirus
Hobbled Huawei
Digital Currency
Fintech / Internet Finance
Selected
CX Daily
Weekly Must-Read
Energy Insider
Economic Indexes
Caixin Explains
Reg Watch
Subscriber Events
ThinkChina
The Wall Street Journal
Market Data
Company Index
Podcast
Highlights
Newsletter
Events
ESG
Promotion
中文
SUBSCRIBE
Clear
GO
Sort by:
Newest
Newest
Relevance
Oldest
Type:
All
All
News
CX Tech
Videos
Podcast
Gallery
In-Depth
Time:
Any Time
Any time
Past 24 Hours
Past Week
Past Month
Past Year
Custom Range
Range:
All
All
Headline
Byline
Full Text
Reset
Showing search results for
cui xiaotian
Cover Story: Anti-Corruption Storm Sweeps China’s Health-Care Industry
China’s Regulators Flag ‘Systemic Corruption’ Risk in Drugs Sector
In Depth: The Budding Market for Microscopic Organ Testing
China Fines Two Chinese Drug Ingredient Suppliers $45.4 Million
Uncertainty Undermines Prospects of China’s Homegrown Covid Antivirals
In Depth: Where Do Fake Covid Drugs Come From?
Chinese Authorities Seize Fake Paxlovid Anti-Covid Pills
In Depth: How Beijing’s Health Care System Battled Covid as Cases Peaked
Analysis: China’s Limits on Dispensing Pfizer’s Paxlovid Could Delay Treatment
China Approves Merck’s Covid Pill Amid Shortage of Drugs
Load more
Sign In
Sign In
Cancel
Remember me
Forgot Password
OR
Sign in with Google
Sign in with Facebook
Sign in with 财新通